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Because the equality of the pulmonary artery wedge
pressure and left atrial pressure has been questioned in
patients with mitral valve disease and pulmonary hy-
pertension, this study examined how vasomotor activity
in the pulmonary capacitance vessels might contribute
to a discrepancy between these pressures. The difference
between the pulmonary wedge and left atrial pressures
(designated as the pulmonary venousgradient) was mea-
sured after nitroglycerin administration in nine patients
who had pulmonary hypertension (mean pulmonary ar-
tery pressure 40 mm Hg) after mitral valvereplacement.
Five minutes after sublingual nitroglycerin, 0.4 mg, the
mean pulmonary wedge pressure decreased from 19 ±
2 to 13 ± 2 mm Hg (p < 0.005), exceedingthe decrease
in left atrial pressure (15 ± 2 to 11 ± 2 mm Hg; p <
0.005). Pulmonary blood flow increased from 4.6 ± 0.4
When a cardiovascular catheter is wedged into a branch of
the pulmonary artery, the pressure waveform transmitted
from its tip reflects that across the pulmonary capillary ves-
sels and has the characteristics of a venous pulse. This
pressure closely resembles that within the left atrium, be-
cause only a minimal gradient between the pulmonary cap-
illary bed and the left atrium is required to propel blood
forward through the pulmonary veins. Cardiac catheteriza-
tion methods for direct measurement of left atrial pressure
are relatively difficult; hence, it has been conventional prac-
tice to employ the pulmonary artery wedge pressure as a
substitute. Although the agreement between these pressures
is close (within I to 2 mm Hg) in individuals with normal
cardiopulmonary physiology, discrepancy has been en-
countered in certain clinical situations, such as in the pres-
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to 4.9 ± 0.4 liters/min (p < 0.005). The decrease in
mean pulmonary venous gradient from 4.0 ± 0.8 to
1.7 ± 0.6 mm Hg (p < 0.025) was attributed to nitrate-
mediated pulmonary venodilation. The ratio of venous
gradient to blood flow, an index of pulmonary venous
tone, decreased after nitroglycerin from 0.9 ± 0.2 to
0.4 ± 0.1 (p < 0.01).
These data indicate that reversible pulmonary vaso-
constriction contributes to elevation of the pulmonary
wedge pressure above the left atrial pressure in patients
with chronlc mitral valve disease and pulmonary hy-
pertension and that nitroglycerin may produce pulmo-
nary venodilation decreasing the pulmonary venous
gradient.
(J Am Coil CardioI1985;5:34-9)
ence of mitral valve disease with reactive pulmonary hy-
pertension, during recovery from cardiopulmonary bypass
and in the presence of very high left ventricular filling pres-
sure (1-6). Substantial differences between pulmonary wedge
and left atrial pressures indicate a potential zone of resistance
to blood flow in the pulmonary venous bed. Dynamic con-
striction of human pulmonary veins has not been previously
verified, although the existence of such capacitance "throt-
tles" has beert the subject of speculation (7).
Nitroglycerin, administered sublingually, displays vaso-
dilator properties that are particularly evident in peripheral
venous beds and it decreases pulmonary artery pressure in
patients with congestive heart failure (8-10). Nitroglycerin
has also been shown to reverse pharmacologically induced
pulmonary venoconstriction in anesthetized dogs, but the
effects of this substance and of other vasodilator drugs on
the human pulmonary venous system have not been estab-
lished (II). To evaluate the possibility that reversible pul-
monary vasoconstriction might contribute to pulmonary hy-
pertension and raise the pulmonary artery wedge pressure
above left atrial pressure in patients recovering from mitral
valve replacement surgery, we administered nitroglycerin
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while measuring both pressures simultaneously. The results
shed light on the pathophysiology of the pulmonary circu-
lation in patients with mitral valve disease and suggest an
action of nitroglycerin on the pulmonary capacitance vessels,
Methods
Patients. Nine patients were studied after elective mitral
valve replacement. Clinical characteristics and preoperative
hemodynamic features are shown in Table I . Studies were
conducted between24 and 96 hours of the surgical procedure
in each patient, after withdrawal of catecholamine and vaso-
dilator medications, Mechanical ventilatory support had
been withdrawn, but oxygen therapy was maintained con-
stantly in these patients and hypoxemia was excluded by
arterial blood gas analysis. All patients were routinely main-
tained on digitalis therapy in the perioperative period, but
none was receiving beta-adrenergic or calcium channel an-
tagonist drugs. The cardiac rhythm was atrial fi brillation in
fi ve patients. atrial-paced in three and ventricular-paced in
one.
Instrumentation and measurements. In conjunction
with the cardiac surgical procedure, patients had a 3.5 mm
polyvinyl left atrial catheter brought through the chest wall.
A transvenous 7F thermodilution Swan-Ganz catheter was
positioned in the pulmonary artery so that pulmonary wedge
pressure could be measured by intermittent balloon inflation.
Wedge pressures were verified by examination of pulse wave
confi guration and by oximetry of blood sampled through
the occluding catheter. accepting those readings associated
with oxygen saturation levels over 95%. An 18gauge Teflon
radial arterial cannula was employed for determination of
blood pressure. These hydraulic catheters were connected
to Statham model P23-lD dome-type strain gauge pressure
transducers independently calibrated against a mercury col-
umn with zero reference at the level of the midaxillary line.
The electrocardiographic signal was concurrently recorded.
Simultaneous recordings of the pulmonary wedge pressure
and the left atrial pressure waveforms from each patient
were made with an Electronics for Medicine model DR-12
multigraph before and after reversal of the equisensitive
transducers to minimize the systematic error of measurement,
The mean arterial . pulmonary wedge and left atrial pres-
sures were determined by electronic integration of phasic
signals. The mean pulmonary venous gradient (PVG) was
determined by transposition and planimetry of the separation
between the equisensitive pulmonary wedge and left atrial
pressure waveform recordings throughout the cardiac cycle
over 10 consecutive beats during phasic respiration. Pul-
monary blood flow(PBF) was measured as right heart output
by the thermodilution technique. using an American Ed-
wards Laboratories model 9520-A computer. averaging at
least three replicate determinations differing by less than
10%, Pulmonaryvenous resistance was calculated according
to the formula (PVG -i- PBF) X 80. yielding results in
dynes-s-cm ' .
Drug intervention and statistical analysis. Stable
baseline hemodynamic status was verified by repeated mea-
surements over 20 minutes. Each patient was then given
sublingual nitroglycerin. 0.4 mg, and measurements of pres-
sure and flow were repeated at the time of peak systemic
hypotensive effect. This dose of nitroglycerin was repeated
5 to 10 minutes later when mean arterial pressure did not
decrease at least 5 mm Hg. Results were expressed as the
mean ± standard error of the mean for measured data and
derived indexes of venous tone. Drug-induced changes were
evaluated by the Student' s t test for paired variables and the
null hypothesis was assessed by means of the unpaired Stu-
dent' s t test. Significance was accepted at a confidence level
of 95%.
Results
Baseline hemodynamic values (Table 2). Pulmonary
hypertension in these patients persisted shortly after mitral
valve replacement. as the mean pulmonary artery pressure
Table l. Preoperative Clinical Characteristics of the Nine Patients
Age (yr)
Case & Sex Diagnosis PA MA MR MG PR
72F TVD.MR 20 3 106
2 7 1F MS 23 0 .54 0 9.7 346
3 7KF AVD.MR.MS 46 3 33 .0 646
4 6 1M AVD. MS 24 0.54 0 13.2 114
5 64F TVD .MR 56 4 18.0
6 52F MR 47 4 \5.0 654
7 34F MS 50 1.10 0 34 .0 135
8 5'JF AVD. MS 27 0 .90 0 12.0 110
9 57M AVD,MS 57 0 .70 0 25 .0 627
AVD = aortic valve disease : MA = mitral valve orifice area (cnr'): MG = diastolic mitral valve gradient
(mm); MR = mitral regurgitation (graded 0 to 4 -t-") ; MS = mitral stenosis; PA = mean pulmonary artery
pressure (mm Hg): PR = pulmonary arteriolar resist ance (dynes -s-cm '); TVD = tricuspid valve disease.
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Table 2. Hemodynamic Data Before and After Nitroglycerin
Case Nitroglycerin LA PW rvo HR AP PBP PYT PYR SY
Before 9 10 1.9 64 68 4.1 0.5 37 64
After 4 6 I.7 62 60 4.0 0.4 34 65
2
Before 18 20 1.5 100 100 3.7 0.4 32 37
After 15 16 0 100 97 4.0 0 0 40
3 Before 17 20 1.4 90 93 3.3 0.4 34 37
After 9 9 0.4 90 80 3.7 0.1 8 41
4
Before 16 16 4.6 89 86 4.2 1.1 87 47
After II 9 0 100 78 4.9 0 0 49
5 Before 25 33 8.1 88 86 4.3 1.9 150 49
After 20 25 4.1 88 73 4.5 0.9 73 51
6 Before 15 18 3.1 100 73 5.0 0.6 50 50After 10 13 3.1 100 68 5.7 0.5 43 57
7 Before 10 12 3.1 90 71 4.2 0.7 59 47After 8 II 3.6 91 65 4.9 0.7 58 54
8 Before 10 16 5.4 100 80 4.7 1.2 91 47
After 9 II 2.7 100 68 4.9 0.6 44 49
9 Before 19 22 7.1 98 74 7.5 0.9 76 77
After 17 16 0 98 72 7.9 0 10 80
Mean Before 15 ± 2 19 ± 2 4.0 ± 0.8 91 ± 4 81 ± 4 4.6 ± 0.4 0.9 ± 0.2 68 ± 13 51 ± 4
± SEM After II ± 2 13 ± 2 I.7 ± 0.6 92 ± 4 73 ± 4 4.9 ± 0.4 0.4 ± 0.1 30 ± 9 54 ± 4
p <0.005 <0.005 <0.025 NS <0.005 <0.005 <0.010 <0.010 <0.005
AP = mean arterial pressure (mm Hg); HR = heart rate (beats/min); LA = mean left atrial pressure (mm Hg); NS = not significant; PBP =
pulmonary blood flow (liters/min); pya = mean pulmonary venous gradient (mm Hg); PYR = pulmonary venous resistance (dynes-s-cm- 5); PYT =
pulmonary venous tone (mm Hg/liters per min); PW = mean pulmonary artery wedge pressure (mm Hg); SY = stroke volume (ml/beat).
averaged 40 ± 4 mm Hg. Mean left atrial pressure ranged
from 9 to 25 mm Hg, averaging 15 mm Hg. This was
exceeded by the mean pulmonary capillary wedge pressure,
which averaged 19 mm Hg. The mean pulmonary venous
gradient, determined by planimetry of the recorded tracings,
ranged from I to 8 mm Hg (average 4). This value was
significantly different from zero (t == 4.64, P < 0.002).
Pulmonary blood flow ranged from 3.3 to 7.5 liters/min
(average 4.6) before administration of nitroglycerin.
Response to nitroglycerin (Table 2). Nitroglycerin
administration was accompanied by a decrease in mean sys-
temic arterial pressure of 8 mm Hg, whereas heart rate was
unchanged (91 ± 4 beats/min). The mean pulmonary wedge
pressure decreased 6 mm Hg whereas mean left atrial pres-
sure changed by only 4 mm Hg, a statistically significant
difference (p < 0.005), bringing the wedge pressure to
13 ± 2 mm Hg and the atrial pressure to 11 ::!: 2 mm Hg
after nitroglycerin (Fig. 1). The mean pulmonary venous
gradient decreased from 4.0 ± 0.8 to 1.7 ± 0.6 mm Hg
in all patients, a small but significant average change of 2.3
± 0.2 mm Hg (p < 0.025) (Fig. 2).
The pulmonary venous blood flow, as measured by ther-
modilution, increased from 4.6 ± 0.4 to 4.9 ± 0.4
liters/min (p < 0.005) as a consequence of vasodilation.
The ratio of pulmonary venous gradient to pulmonary blood
flow, an index of pulmonary venous tone, decreased in all
patients after nitroglycerin from an average value of 0.9 ±
0.2 to 0.4 ± 0.1 mm Hg per liters/min (p < 0.010) (Fig.
3). This corresponds to a reduction in effective regional
pulmonary venous resistance from 68 ± 13 to 30 ± 9
dynes·s·cm - 5 as a result of nitroglycerin activity.
Figure 4 demonstrates pressure waveform recordings be-
fore and after nitroglycerin along with measurements of
pulmonary blood flow in Patient 5. Narrowing of the sep-
aration between the pulmonary wedge and left atrial tracings
occurred as the absolute levels of each pressure decreased,
whereas cardiac output increased slightly. This example is
representative of the decrease in pulmonary venous gradient
observed with nitroglycerin in our patients.
Discussion
Pulmonary wedge-left atrial pressure relation. In these
patients with mitral valve disease and pulmonary hyperten-
sion, the mean pulmonary artery wedge pressure was not
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Figure 1. Mean pulmonary capillary wedge pressure, mean left
atrial pressure and pulmonary blood flow before and after nitro-
glycerin in all nine patients (mean ± SEM).
an accurate reflection of left atrial pressure, A consistent
gradient was present between the pulmonary wedge and left
atrial levels of the circulation and it is reasonable to attribute
this to resistance imposed by the pulmonary microcircula-
tion and the pulmonary veins, though arteriolar factors can-
not be excluded. Werko, Bjork, Hosenpud and their co-
workers (1,2,6) previously provided measurements of
simultaneously determined pulmonary wedge and left atrial
pressures in patients with mitral valve disease. The differ-
ences between the pulmonary wedge pressures and left atrial
pressures they observed ranged from negligible values to
nearly II mm Hg, but were generally 5 to 7 mm Hg in
patients with a stenotic mitral valve. Several investigators
(3,4, 12, 13) reported that the normal correlation of pulmo-
nary wedge pressure with left atrial and left ventricular
diastolic pressure was distorted before and after cardiac
surgery in the presence of elevated pulmonary vascular re-
sistance. Walston and Kendall (5) described considerable
variation between these values when the pulmonary wedge
pressure exceeded 10 mm Hg in patients undergoing di-
agnostic cardiac catheterization.
More recently, Mammana et al. (4) measured pulmonary
wedge pressure and left atrial pressure simultaneously after
cardiopulmonary bypass and found that the pulmonary wedge
pressure exceeded the left atrial pressure in the early post-
bypass period despite equilibration before surgery and sev-
eral days later. This disparity was thought to be related to
pulmonary interstitial fluid overload resulting from hemo-
Figure 2. Mean pulmonary venous pressure gradient in each pa-
tient before and after nitroglycerin (mean ± SEM).
dilution, to lung microvascular injury or to the effects of
vasoactive drugs on pulmonary veins. In their study, nitro-
glycerin was routinely administered to patients until the
onset of cardiopulmonary bypass at which time it was with-
drawn. Pulmonary venoconstriction was suspected in these
patients, but the effective resistance of this regional circu-
lation cannot be estimated from the data because the pul-
monary blood flow was not reported. Kurmoto and Rodbard
( 13) demonstrated more than two decades ago that the de-
Figure 3. Calculated index of pulmonary venous tone in each
patient before and after nitroglycerin (mean ± SEM).
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Figure 4. Patient 5. Simultaneous pressure recordings obtained
before and after nitroglycerin demonstrating the decline in pul-
monary venous gradient. EKG = electrocardiogram.
tigation. Burch and Romney (15) described histologic stud-
ies showing that the vascular walls of the pulmonary venous
system are rich in smooth muscle and autonomic innerva-
tion, and they proposed that constriction of pulmonary veins
was a mechanism by which left ventricular inflow could be
limited. Estimates of the contribution of pulmonary venous
tone to the total vascular resistance of the pulmonary circuit
range from negligible values up to 25 or 50% (13.16-18 ).
In our patients, the data suggest that venous tone accounted
for about 15% of the total resistance across the pulmonary
circuit; thi-s fraction was reduced to less than 5% by nitro-
glycerin. The small but statistically signifi cant increase in
cardiac output that we observed reflects improved right ven-
tricular stroke volume because heart rate did not change.
Increased blood flow may have resulted in part from the
reduced impedance to pulmonary flow as the effective pul-
monary venous tone decreased by half. These results also
suggest that augmentation of pulmonary venous capacitance
may contribute directly to reduced left ventricular preload,
although the influence of lower blood pressure cannot be
discounted.
Methodologic considerations. When the Swan-Ganz
catheter is wedged into a distal branch of the pulmonary
artery, it blocks flow into the contiguous capillary bed and
registers pressure in that portion of the pulmonary vascu-
lature which is in free communication with the digital tip.
This segment of the pulmonary circulation includes arter-
ioles, capillaries, venules and the confl uent pulmonary veins.
The technique of measuring pulmonary wedge pressure us-
ing a pulmonary artery catheter and extrapolating this to left
heart diastolic pressures may underestimate the degree of
obstruction posed by the microvasculature or the larger pul-
monary veins. In the patients we studied. there was better
agreement between the pulmonary wedge and left atrial
pressure levels after nitroglycerin administration. The pos-
sibility of gravitational error caused by unequal heights of
the intravascular tips of the left atrial and pulmonary artery
catheters was not excluded by fl uoroscopy. It seems un-
likely, however. that any randomdiscrepancy between these
catheter tip levels could account for the consistent obser-
vations by several investigators of pulmonary wedge pres-
sure exceeding left atrial pressure in patients such as ours.
Even if the initial pulmonary venous gradient was artifac-
tual, however, its diminution with nitroglycerin could hot
be explained by gravitational or transducer factors. Indeed,
its reversibility supports the contention that a difference
between wedge and atrial pressures exists.
The limitations of this study derive partly from the va-
garies of pressure measurements obtained with fluid-filled
catheter systems, and, hence, the inability to obtain reliable
measurements of phasic pulmonary arterial pressures. Fur-
thermore, the impact of pulmonary venous tone on central
and systemic hemodynamics may vary with time after car-
diopulmonary bypass, and it is likely that the fluid status
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crease in pressure between the pulmonary venules and left
atrium of anesthetized dogs may account for up to half of
the total gradient between the pulmonary artery and left
atrium. Our findings support the view that reversible pul-
monary venoconstriction is_responsible for raising pulmo-
nary wedge pressure over left atrial pressure in patients with
reactive pulmonary hypertension after mitral valve
replacement.
Action of nitroglycerin. The systemic vasodilator ef-
fects of nitroglycerin are most pronounced on peripheral
veins. yet it is well recognized that organic nitrates lower
left ventricular filling pressure by reducing both venous
return and peripheral resistance (8, 10). Pulmonary artery
pressure and pulmonary wedge pressure decrease after
administration of nitroglycerin in patients with congestive
heart failure, but this has been attributed to the decrease in
left atrial (and hence pulmonary venous) pressure. This, in
tum, is ascribed to a reduction in systemic venous return
and lowering of the aortic impedance to left ventricular
emptying, but there is evidence that nitroglycerin produces
direct pulmonary arteriolar dilation (I I). Mookherjee et al.
(14) observed that nitroglycerin produced pulmonary va-
sodilation even when cardiac output and systemic vascular
resistance were unchanged. Whether the pulmonary vaso-
dilator properties of nitroglycerin involve relaxant effects
on arterial or venous beds has remained an unsettled issue.
Pulmonary venous hemodynamics. The vasomotor
physiology of the pulmonary veins is central to this inves-
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of the patients, the autonomic nervous system and metabolic
factors playa role.
Clinical implications. Clinical application of hydraulic
formulas to the determination of the severity of mitral ste-
nosis often depends on the faithfulness with which left atrial
pressure is reflected in the pulmonary wedge pressure and
whether reversible pulmonary venoconstriction in such cases
could raise the regional resistance to blood flow independent
of arteriolar and atrial tone, leading to overestimation of the
severity of mitral stenosis. Hosenpud et al. (6) reported
discrepancies of this sort in mitral orifice calculations rang-
ing from 0 to 0.7 ern". In such circumstances, measurements
made after administration of nitroglycerin might lead to
more accurate estimates of valve orifice area, but extrap-
olation of our observations to nonsurgical cases or to patients
without mitral valve disease and pulmonary hypertension is
unfounded. Finally, the clinical significance of changes of
the magnitude we observed and the importance of pulmo-
nary venous tone to other clinical states of pulmonary hy-
pertension, congestive heart failure or interstitial pulmonary
edema remain to be established.
It seems clear, nevertheless, that an abnormal pulmonary
pressure gradient is present in some patients with mitral
valve disease after valvular surgery and that reversible pul-
monary venoconstriction may contribute to elevation of the
pulmonary wedge pressure above the left atrial pressure.
We found no evidence, however, to devalue the pulmonary
wedge pressure as a reflection of directional changes in left
heart diastolic pressure. Nitroglycerin produces systemic
and probably pulmonary venodilation, nearly abolishing this
gradient and increasing cardiac output. Use of this drug
favorably influences hemodynamic function and dissipates
much of the error inherent in pulmonary wedge pressure
measurements for estimation of left heart filling pressure.
We are grateful to Ruby S. Gordon for skilled secretarial assistance.
References
I. Werko L, Varnauskas E. Eliasch H. Lagerlof H. Senning A. Thom-
asson B. Further evidence that the pulmonary capillary venous pressure
pulse in man reflects cyclic pressure changes in the left atrium. Circ
Res 1953; I:337-9.
2. Bjork YO. Malmstrom G. Uggula LG. Left auricular pressure mea-
surements in man. Ann Surg 1953;138:718-25.
3. Lappas D. Lell WA. Gabel JG. Civetta JM. Lowenstein E. Indirect
measurements of left atrial pressure in surgical patients: pulmonary-
capillary wedge and pulmonary-artery diastolic pressures compared
with left atrial pressure. Anesthesiology 1973;38:394-7.
4. Mammana RB. Hiro S. Levitsky S, Thomas PA, Plachetka J. Inac-
curacy of pulmonary capillary wedge pressure when compared to left
atrial pressure in the early postsurgical period. J Thorac Cardiovasc
Surg 1982;84:420-5.
5. Walston A. Kendall ME. Comparison of pulmonary wedge and left
atrial pressure in man. Am Heart J 1973;86: 159-64.
6. Hosenpud JD. McAnulty JH. Morton MJ. Overestimation of mitral
valve gradients obtained by phasic pulmonary capillary wedge pres-
sure. Cathet Cardiovasc Diagn 1983:9:283-90.
7. Fishman AP. Dynamics of the pulmonary circulation. In: Hamilton
WF. Dow P. eds. Handbook of Physiology. Baltimore: Waverly Press.
1963:1667-743.
8. Mason DT, Braunwald E. The effects of nitroglycerin and amyl nitrate
on arteriolar and venous tone in the human forearm. Circulation
1965;32:755-66.
9. Johnson JB. Gross JF. Hale E. Effects of sublingual administration
of nitroglycerin on pulmonary artery pressure in patients with failure
of the left ventricle. N Engl J Med 1957;257:1114-7.
10. Franciosa JA. Nordstrom LA. Cohn IN. Nitrate therapy for congestive
heart failure. JAMA 1978:240:443-6.
II. Kadowitz PJ. Joiner PD. Hyman AL. Influence of sympathetic stim-
ulation and vasoactive substances on the canine pulmonary veins. J
Clin Invest 1975:56:354-65.
12. Falicov RE. Resnekov L. Relationship of the pulmonary artery end-
diastolic pressure to t'he left ventricular end-diastolic and mean filling
pressures in patients with and without left ventricular dysfunction.
Circulation 1970;42:65-73.
13. Kuramoto K. Rodbard S. Effects of blood flow and left atrial pressure
on pulmonary venous resistance. Circ Res 1962;11:240-6.
14. Mookherjee S. Fuleihan D. Warner RA. Vardan S. Obeid AL. Effects
of sublingual nitroglycerin on resting pulmonary gas exchange and
hemodynamics in man. Circulation 1978:57: 106-10.
IS. Burch GE. Romney RB. Functional anatomy and "throttle valve"
action of the pulmonary veins. Am Heart J 1954;47:58-66.
16. Stern S. Braun K. Effects of chemoreceptor stimulation on the pul-
monary veins. Am J Physiol 1966:210:535-9.
17. Aviado DM. Pulmonary venular responses to anoxia. 5-hydroxytrypt-
amine and histamine. Am J Physiol 1960;198:1032-6.
18. Hyman AL. Burch GE. DePasquale NP. Tyler JM. Spontaneous vari-
ations in pulmonary venous pressure in intact dogs. Proc Soc Exp Bioi
Med 1963;112:1032-7.
